UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blocking transforming growth factor–beta up‐regulates E‐cadherin and reduces migration and invasion of hepatocellular carcinoma cells

Hepatology (Baltimore, Md.), 2008-05, Vol.47 (5), p.1557-1566

2008

Volltextzugriff (PDF)

Activated Integrin αvβ3 Cooperates with Metalloproteinase MMP-9 in Regulating Migration of Metastatic Breast Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (16), p.9482-9487

2003

Volltextzugriff (PDF)

Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin

The American journal of pathology, 2002-07, Vol.161 (1), p.183-193

2002

Volltextzugriff (PDF)

Integrin Activation Controls Metastasis in Human Breast Cancer

Proceedings of the National Academy of Sciences - PNAS, 2001-02, Vol.98 (4), p.1853-1858

2001

Volltextzugriff (PDF)

Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients

Clinica chimica acta, 2007-08, Vol.383 (1-2), p.147-152

2007

Volltextzugriff (PDF)

Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma

International journal of cancer, 2002-02, Vol.97 (4), p.425-431

2002

Volltextzugriff (PDF)

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC

Molecular cancer, 2009-05, Vol.8 (1), p.29-29, Article 29

2009

Volltextzugriff (PDF)

Laminin-5 Chains Are Expressed Differentially in Metastatic and Nonmetastatic Hepatocellular Carcinoma

Clinical cancer research, 2003-09, Vol.9 (10), p.3684-3691

2003

Volltextzugriff (PDF)

HCC heterogeneity: molecular pathogenesis and clinical implications

Cellular oncology : the official journal of the International Society for Cellular Oncology, 2009, Vol.31 (3), p.227-233

2009

Volltextzugriff (PDF)

Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2009-03, Vol.49 (3), p.839-850

2009

Volltextzugriff (PDF)

Inhibition of transforming growth factor β receptor I kinase blocks hepatocellular carcinoma growth through neo‐angiogenesis regulation

Hepatology (Baltimore, Md.), 2009-10, Vol.50 (4), p.1140-1151

2009

Volltextzugriff (PDF)

Down‐regulation of connective tissue growth factor by inhibition of transforming growth factor β blocks the tumor–stroma cross‐talk and tumor progression in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.523-534

2010

Volltextzugriff (PDF)

Inhibiting TGF-β signaling in hepatocellular carcinoma

Biochimica et biophysica acta, 2011-04, Vol.1815 (2), p.214-223

2011

Volltextzugriff (PDF)

Hepatic stellate cells stimulate HCC cell migration via laminin-5 production

Clinical science (1979), 2011-08, Vol.121 (4), p.159-168

2011

Volltextzugriff (PDF)

Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study

Cancer chemotherapy and pharmacology, 2011-07, Vol.68 (1), p.79-86

2011

Volltextzugriff (PDF)

Human Hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion

Laboratory investigation, 2001-04, Vol.81 (4), p.613-627

2001

Volltextzugriff (PDF)

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells

Clinical & experimental metastasis, 2002, Vol.19 (5), p.427-436

2002

Volltextzugriff (PDF)

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor [beta] blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.523

2010

Volltextzugriff (PDF)

Kinase activation profile associated with TGF-[beta]-dependent migration of HCC cells: a preclinical study

Cancer chemotherapy and pharmacology, 2011-07, Vol.68 (1), p.79

2011

Volltextzugriff (PDF)

Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients

International journal of cancer, 2004-05, Vol.109 (5), p.782-785

2004

Volltextzugriff (PDF)

HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications

Analytical cellular pathology (Amsterdam), 2009-01, Vol.31 (3), p.227-233

2009

Volltextzugriff (PDF)

Clinical Role of Serum and Tissue Matrix Metalloprotease-9 Expression in Chronic HCV Patients Treated with Pegylated IFN-α2b and Ribavirin

Journal of interferon & cytokine research, 2005-08, Vol.25 (8), p.453-458

2005

Volltextzugriff (PDF)

Gelatinase Levels in Male and Female Breast Cancer

Biochemical and biophysical research communications, 2002-03, Vol.292 (1), p.161-166

2002

Volltextzugriff (PDF)

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2009-03, Vol.49 (3), p.839-850

2009

Volltextzugriff (PDF)

Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes

Journal of interferon & cytokine research, 2006-05, Vol.26 (5), p.301

2006

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Tumors
(14)
Female
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Carcinoma, Hepatocellular - Pathology
(10)
Gastroenterology. Liver. Pancreas. Abdomen
(10)
Liver Neoplasms - Pathology
(10)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(10)
Male
(10)
Middle Aged
(10)
Aged
(9)
Carcinoma, Hepatocellular - Metabolism
(9)
Liver Neoplasms - Metabolism
(9)
Oncology
(8)
Animals
(7)
Biochemistry & Molecular Biology
(7)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blocking transforming growth factor–beta up‐regulates E‐cadherin and reduces migration and invasion of hepatocellular carcinoma cells

Activated Integrin αvβ3 Cooperates with Metalloproteinase MMP-9 in Regulating Migration of Metastatic Breast Cancer Cells

Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin

Integrin Activation Controls Metastasis in Human Breast Cancer

Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients

Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC

Laminin-5 Chains Are Expressed Differentially in Metastatic and Nonmetastatic Hepatocellular Carcinoma

HCC heterogeneity: molecular pathogenesis and clinical implications

Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma

Inhibition of transforming growth factor β receptor I kinase blocks hepatocellular carcinoma growth through neo‐angiogenesis regulation

Down‐regulation of connective tissue growth factor by inhibition of transforming growth factor β blocks the tumor–stroma cross‐talk and tumor progression in hepatocellular carcinoma

Inhibiting TGF-β signaling in hepatocellular carcinoma

Hepatic stellate cells stimulate HCC cell migration via laminin-5 production

Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study

Human Hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor [beta] blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma

Kinase activation profile associated with TGF-[beta]-dependent migration of HCC cells: a preclinical study

Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients

HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications

Clinical Role of Serum and Tissue Matrix Metalloprotease-9 Expression in Chronic HCV Patients Treated with Pegylated IFN-α2b and Ribavirin

Gelatinase Levels in Male and Female Breast Cancer

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma

Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes

Suchergebnisse filtern